Neil Exter's investments in Pliant Therapeutics have seen significant ups and downs. His insider trading activity peaked in mid-2021 when he sold shares valued at nearly $2.6 million in June. In 2022, he continued trading, with transactions averaging around $2...

Neil Exter's investments in Pliant Therapeutics have seen significant ups and downs. His insider trading activity peaked in mid-2021 when he sold shares valued at nearly $2.6 million in June. In 2022, he continued trading, with transactions averaging around $2 million monthly in the latter part of the year. By the start of 2023, Exter's holdings remained robust, reflecting his confidence in the company's direction, with sales from before attributed to market movements and company performance. His stake indicates that a substantial portion of his net worth has closely tied to the company's success, especially given that his trades often aligned with strategic milestones within Pliant.